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Abstract
The article describes a case of severe acute
lactic acidosis and hypoglycemia after inten-
tional ingestion of tramadol overdose.
Introduction
Tramadol is a widely used synthetic, central-
ly acting analgesic with both opioid and non-
opioid actions.1,2 The drug has low affinity for
μ- and κ-opioid receptors, and exerts inhibito-
ry effects of the reuptake of both norepineph-
rine and serotonin (5-hydroxytryptamine).2 It
has also been demonstrated that tramadol
stimulates the dopamine (D2) receptors and
inhibits the gamma amino butyric acid (GABA)
release in central nervous system.3,4 This phar-
macodynamic complexity translates into a
wide range of clinical actions and even toxic
effects, which are often not fully predictable.
Briefly, tramadol is an increasingly used anal-
gesic drug, available as both parenteral and
enteral formulations, originally introduced in
Germany in the late 1970s as a weak opioid
with atypical clinical profile.5 Common thera-
peutic doses of tramadol are comprised
between 100 and 400 mg/day.2,6
Up to 90% percent of tramadol is excreted in
the urine, ~30% of which as unmetabolized
drug. About 10% is metabolized by N- and O-
demethylation, followed by conjugation with
glucuronic acid and sulfate. O-desmethyltra-
madol (ODT) is an active metabolite display-
ing 2 to 4 times the analgesic activity of the
parent drug and longer half-life, so sharing
also some toxic effects of the parent com-
pound.7,8
Soon after the approval, tramadol abuse,
misuse, and overdose have been increasingly
observed worldwide due to its opioid proper-
ties.9-11 The most frequent side effects at ther-
apeutic dosages include nausea, dizziness,
somnolence, drowsiness, enhanced sweating,
vomiting and dry mouth.12,13 Both in therapeu-
tic and toxic doses, seizure and apnea have
been reported as the most severe adverse reac-
tions,9,10,14 along with hypoglycemia, hyperamy-
lasemia, liver and kidney dysfunctions.15,16 As
such, evaluation of laboratory findings includ-
ing plasma electrolytes, blood gas analysis, kid-
ney and liver function tests play a pivotal role
for patient monitoring in the suspicion or con-
firmed diagnosis of tramadol poisoning and/or
toxicity. 
We describe here a case of severe lactic aci-
dosis triggered by a tramadol intentional over-
dose.
Case Report
A 33-year-old man was brought to the
Emergency Department (ED) of the Academic
Hospital of Parma for stupor and respiratory
depression. He was usually taking clonazepam,
trazodone and biperidene, all administered at
appropriate dosage by prison officers, since
the time he has been jailed, 3 years before. At
ED presentation the patient was unresponsive,
midriatic, bradypneic, normotensive (110/60
mmHg). No convulsions have been witnessed
and/or recorded. Immediately after ED admis-
sion, abundant vomiting of gastric juice start-
ed. The patient was hence immediately treated
with intravenous (i.v.) glucose 33% 20 mL,
naloxone 0.8 mg and flumazenil 1 mg, obtain-
ing only a partial response. An additional dose
of naloxone 0.8 mg i.v. was then administered,
obtaining a relative full recovery of conscious-
ness. A gastric lavage and an administration
(through naso-gastric tube) of activated char-
coal 50 g were then established, followed by
administration of magnesium sulphate 30 g.
Two hours later the patient become again
unresponsive, thus leading to the additional
administration of naloxone 0.8 mg, which was
followed by prompt clinical response. The
essential blood tests were characterized by:
neutrophilic leukocytosis (WBC 21.1x109/L;
neutrophils 16. 8x109/L); hypoglycemia (serum
glucose 39 mg/dL); acute renal failure (serum
creatinine 2.7 mg/dL; eGFR assessed with to
the CKD-EPI equation, 32 mL/min); slight
increase of lipase (64 U/L; upper limit of the
reference range, 58 U/L); moderate increase of
troponin I (1.2 ng/mL, upper limit of the refer-
ence range, 0.05 ng/mL); moderate and tran-
sient increase of alanine-aminotransferase
(ALT; 471 U/L; upper limit of the reference
range, 40 U/L); slight positivity for quantitative
benzodiazepines and/or their metabolites
assay in urine; ethanol was absent in the blood
sample. We did not search for salicylates, met-
formin, and iron (all potential triggers of lactic
acidosis), since the patient did not have access
to these drugs (he was jailed, as previously
reported). The value of creatine kinase (CK), a
well-established biomarker of rhabdomyolysis
(i.e., a frequent complication of opioid and tra-
madol overdose),17,18 was normal. The electro-
cardiogram (ECG) remained always normal.
An echocardiogram, prescribed to investigate
the nature of the troponin increase, failed to
show contractility defects. A severe and wors-
ening lactic acidosis, initially associated with
respiratory acidosis, was however observed
(Table 1), and slowly improved during the first
24 hours of hospital staying. 
Approximately 2 hours after ED admission, a
prison officer brought to the emergency physi-
cian six empty bottles of tramadol (drops)
detected in the jail cell of the patient, corre-
sponding to a total dosage of ~6000 mg. No
other substances were found in the prison.
The officer also informed us that the patient
ate some food (an usual dinner) about 7 hours
before the clinical manifestations. He also con-
firmed, with provisional documentation, that
the patient did not suffer from other diseases.
A frozen vial of the patient’s blood was then
sent to a specialized laboratory for assessment
of tramadol and O-demethyl-tramadol (the
main metabolite), which yielded blood concen-
trations of 26.1 mg/dL of tramadol (largely
exceeding the serum therapeutic ranhe of
0.28-0.61 mg/dL) and 5.3 mg/dL of O-demethyl-
tramadol, respectively.19 Interestingly, it was
lately found that the patient had obtained the
tramadol bottles by another jailed man, who
was using the drug for chronic post-traumatic
pain.
During the hospital staying the patient
underwent a magnetic resonance imaging
(MRI) of the brain, heart and abdomen, which
did not show any pathological findings.
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Discussion
Hypoglycemia has been extensively
described as a possible, albeit rare, adverse
effect of tramadol, even at therapeutic
dosages, surprisingly especially in patients
without a history of diabetes mellitus, and not
taking anti-diabetic drugs.20 Our case is, how-
ever, the very first case report of severe acute
lactic acidosis triggered by tramadol, although
in presence of concomitant transient and
promptly corrected hypoglycemia.  
Theoretically, some metabolic interactions
between tramadol and the other drugs taken by
the patient (in particular clonazepam that is
extensively metabolized in the liver) are con-
ceivable, but unfortunately it was impossible
for us to demonstrate this possibility.
It is also conceivable that some form of
interaction between tramadol and trazodone
(chronically taken by the patient at therapeutic
dosages) could be occurred, but we obviously
did not have the resources to demonstrate it.
A single case of tramadol toxicity leading to
refractory shock and asystole has been previ-
ously described.21 The patient, however, took a
massive overdose of tramadol, alongside with
hydroxyzine, gabapentin, and clonazepam. He
had a long-lasting seizure, hypotension,
hypothermia, and a prolonged QTc at the ECG,
thus showing several clinical characteristics
that clearly distinguished he from the case
here described.
Conclusions
In conclusion, tramadol poisoning should
always be considered in the differential diag-
nosis of metabolic (most of all lactic) acidosis,
especially when obvious or alternative diag-
noses are unlikely.
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Table 1. Blood gases and acid-base balance values during the first day of hospital staying. 
                                                                      Time (h.min)
                                     9.49            11.01           12.13          12.51           17.27          22.05
pH                                           7.007                 6.979                7.054                 7.19                   7.37                 7.42
pCO2 (mmHg)                       60.1                   67.7                  48.1                  45.2                   44.9                 44.8
pO2 (mmHg)                          79.1                   78.3                  75.5                  86.1                   91.4                 94.3
HCO3 (mmol/L)                    14.3                   13.7                  12.8                  17.4                   19.2                 23.7
BE (mmol/L)                        -18.2                  -18.3                 -17.9                 -8.1                    -4.9                  -1.1
Na (mmol/L)                          145                    142                   143                   144                    142                  143
K (mmol/L)                             3.8                      4.5                    4.8                    4.7                     4.6                   4.6
Anion gap (mmol/L)            19.9                   16.3                  17.0                  12.5                   11.7                 11.2
Lactate  (mmol/L)                10.6                   11.3                  10.4                   7.3                     3.8                   2.1
Glucose (mg/dL)                   64                      88                     99                    101                     98                    97
BE, base excess.
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